Skip to main content
. 2017 Oct 30;2017:1052976. doi: 10.1155/2017/1052976

Figure 2.

Figure 2

The estimated cumulative incidence of chronic hepatitis of those treated with CHM or none in the patients with breast cancer cohort by Kaplan–Meier analysis.